A Standardized Approach to Transition Improves Care of Young Adults with Inflammatory Bowel Disease

Daphna Katz1,2, Stephanie Lee2,3, Vidiya Sathananthan2,3

  • 1From the Division of Pediatric Gastroenterology, Hepatology and Nutrition, University of Miami, Miami, Fla.

PubMed

Insights

Improving the transition of care for young adults with inflammatory bowel disease (IBD) is crucial. Interventions increased transition discussions and transfer initiation rates, enhancing patient care without increasing visit duration.

Area of Science:

  • Gastroenterology
  • Pediatric Healthcare
  • Transition of Care Medicine

Background:

  • Young adults with inflammatory bowel disease (IBD) face risks of poor outcomes during the transition from pediatric to adult healthcare providers.
  • Effective care transition strategies are essential to mitigate these risks and ensure continuity of care.

Purpose of the Study:

  • To increase the percentage of patients aged 14-17 undergoing care transition and patients aged 18-21 initiating transfer to adult IBD providers.
  • To enhance patient satisfaction with the care transition process.
  • To ensure the duration of IBD visits does not increase as a balancing measure.

Main Methods:

  • Implementation of three interventions using iterative plan-do-study-act cycles over 12 months.
  • Statistical process control charts were used to analyze intervention impact.
  • Anonymous electronic health record-based satisfaction surveys were administered.

Main Results:

  • Total transition discussions increased to a mean of 38%.
  • Initiation of transfer of care for patients aged 18-21 increased significantly, reaching a mean of 30% after the second and third interventions.
  • No significant difference in IBD visit duration was observed (P = 0.54), and patient satisfaction remained high.

Conclusions:

  • The implemented interventions represent successful initial steps in a new process for transitioning young adults with IBD.
  • Improved transition discussion and transfer initiation rates were achieved.
  • The study highlights the feasibility of enhancing IBD care transitions for young adults.
Abstract

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
315
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
116
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
110
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
95
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
141
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
183